ArticleOncoimmunology

M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine.

Karin M Knudson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.